rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1997-9-19
|
pubmed:abstractText |
Fluid retention is a phenomenon associated with taxoids. The principal objective of this study was to investigate the pathophysiological mechanism of docetaxel-induced fluid retention in advanced cancer patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0306-5251
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
653-8
|
pubmed:dateRevised |
2009-10-2
|
pubmed:meshHeading |
pubmed-meshheading:9205828-Adenocarcinoma,
pubmed-meshheading:9205828-Adrenal Cortex Hormones,
pubmed-meshheading:9205828-Adult,
pubmed-meshheading:9205828-Aged,
pubmed-meshheading:9205828-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9205828-Breast Neoplasms,
pubmed-meshheading:9205828-Dose-Response Relationship, Drug,
pubmed-meshheading:9205828-Drug Therapy, Combination,
pubmed-meshheading:9205828-Edema,
pubmed-meshheading:9205828-Female,
pubmed-meshheading:9205828-Flavonoids,
pubmed-meshheading:9205828-Humans,
pubmed-meshheading:9205828-Infusions, Intravenous,
pubmed-meshheading:9205828-Lymphatic System,
pubmed-meshheading:9205828-Middle Aged,
pubmed-meshheading:9205828-Neoplasm Invasiveness,
pubmed-meshheading:9205828-Ovarian Neoplasms,
pubmed-meshheading:9205828-Paclitaxel,
pubmed-meshheading:9205828-Taxoids,
pubmed-meshheading:9205828-Water-Electrolyte Balance
|
pubmed:year |
1997
|
pubmed:articleTitle |
The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication.
|
pubmed:affiliation |
Hôtel-Dieu, Paris, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|